Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutations.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutations.
Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutations. Leuk Res. 2011 Dec; 35(12):1611-5.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Algorithms
Cytogenetic Analysis
Female
fms-Like Tyrosine Kinase 3
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Mutation
Prognosis
Retrospective Studies
Survival Analysis
Tandem Repeat Sequences
authors with profiles
Donna S. Neuberg, D.Sc.
Martha Wadleigh, M.D.
Philip Crawford Amrein, M.D.
Richard M. Stone, M.D.
Daniel J. DeAngelo, Ph.D., M.D.
Harshabad Singh, M.B.,B.S.